Skip to content

COVID-19 Response

Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN

COVID-19 Response

Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN

Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN

Company
Products
Research & Development
- Our Approach
Investors
Scientific Publications
Resources

LATEST NEWS: Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study

Company
Products
Research & Development
- Our Approach
Investors
Scientific Publications
Resources

Analysis of RFS and DMFS for combined DecisionDx-Melanoma and SLN predicted outcomes

Post navigation

← Previous Media

Connect with Us

Company

About Us
Our History
Leadership
- Board of Directors
Licenses
Careers
Contact Us

Products

Cutaneous Melanoma
Cutaneous SCC
- DecisionDx-SCC
Uveal Melanoma
Barrett’s Esophagus
- TissueCypher
Mental Health
- IDgenetix

Research & Development

Our Approach

Latest News & Publications

Press Releases
Scientific Publications
Email Alerts

Resources

Healthcare Professionals
- Login/Register
- Order A Test
Patients

Copyright © 2023 Castle Biosciences, Inc. | All Rights Reserved

Privacy Policy
Terms of Use
Contact Us